David Usher

2.6k total citations
46 papers, 1.9k citations indexed

About

David Usher is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Usher has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Surgery and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Usher's work include Lipoproteins and Cardiovascular Health (13 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). David Usher is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). David Usher collaborates with scholars based in United States, Netherlands and Germany. David Usher's co-authors include Daniel J. Rader, William J. Cain, Loren A. Zech, Kazuhisa Tsukamoto, Ellen Puré, Sam Chun, Rajendra K. Tangirala, H. Bryan Brewer, Katsunori Ikewaki and Shui Qing Ye and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

David Usher

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Usher United States 22 1.0k 611 564 436 304 46 1.9k
D R van der Westhuyzen South Africa 28 1.5k 1.5× 532 0.9× 1.3k 2.3× 494 1.1× 221 0.7× 47 2.6k
Carole L. Banka United States 20 564 0.6× 396 0.6× 478 0.8× 172 0.4× 400 1.3× 31 1.6k
Shangzhe Xu United States 9 1.5k 1.5× 669 1.1× 1.2k 2.2× 508 1.2× 325 1.1× 10 2.8k
Gaétan Mayer Canada 28 1.4k 1.3× 296 0.5× 1.2k 2.2× 373 0.9× 359 1.2× 65 3.3k
Ann L. White United States 26 1.1k 1.1× 372 0.6× 1.1k 2.0× 364 0.8× 834 2.7× 48 2.9k
Lita A. Freeman United States 35 1.5k 1.4× 783 1.3× 1.3k 2.4× 439 1.0× 245 0.8× 73 3.2k
Scott Mellis United States 16 797 0.8× 209 0.3× 1.3k 2.4× 142 0.3× 858 2.8× 33 2.7k
Richard J. Pease United Kingdom 30 1.5k 1.5× 1.3k 2.2× 2.1k 3.7× 725 1.7× 320 1.1× 60 4.4k
Klaus Stensgaard Frederiksen Denmark 24 378 0.4× 428 0.7× 931 1.7× 378 0.9× 785 2.6× 46 2.5k
Noriyuki Koyama Japan 24 350 0.3× 113 0.2× 821 1.5× 549 1.3× 189 0.6× 64 2.1k

Countries citing papers authored by David Usher

Since Specialization
Citations

This map shows the geographic impact of David Usher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Usher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Usher more than expected).

Fields of papers citing papers by David Usher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Usher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Usher. The network helps show where David Usher may publish in the future.

Co-authorship network of co-authors of David Usher

This figure shows the co-authorship network connecting the top 25 collaborators of David Usher. A scholar is included among the top collaborators of David Usher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Usher. David Usher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nijstad, Niels, Jan Freark de Boer, William R. Lagor, et al.. (2011). Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1811(4). 294–299. 32 indexed citations
2.
Rappaport, Elizabeth B. & David Usher. (2006). Obesity, Insulin Resistance, and Type 2 Diabetes in Children and Adolescents. Pediatric Annals. 35(11). 822–826. 4 indexed citations
3.
Cain, William J., John S. Millar, Adam S. Himebauch, et al.. (2005). Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. Journal of Lipid Research. 46(12). 2681–2691. 81 indexed citations
4.
Ikewaki, Katsunori, William J. Cain, Thomas Fairwell, et al.. (2004). Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency. Journal of Lipid Research. 45(7). 1302–1311. 10 indexed citations
5.
Caird, John, Francesca Brett, Jack Phillips, et al.. (2003). Apolipoprotein(a) Expression in Intracranial Aneurysms. Neurosurgery. 52(4). 854–859. 9 indexed citations
6.
Cain, William J., Li Song, G. A. Stephens, & David Usher. (2003). Characterization of lipoproteins from the turtle, Trachemys scripta elegans, in fasted and fed states. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 134(4). 783–794. 6 indexed citations
7.
Ye, Shui Qing, David Usher, & Li Q. Zhang. (2002). Gene Expression Profiling of Human Diseases by Serial Analysis of Gene Expression. Journal of Biomedical Science. 9(5). 384–394. 18 indexed citations
8.
Ye, Shui Qing, David Usher, & Li Q. Zhang. (2002). Gene expression profiling of human diseases by serial analysis of gene expression. Journal of Biomedical Science. 9(5). 384–394. 27 indexed citations
9.
Rodríguez, Annabelle & David Usher. (2002). Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages. Atherosclerosis. 161(1). 45–54. 26 indexed citations
10.
Jamieson, Dara G., Li Fu, David Usher, & Ehud Lavi. (2001). Detection of Lipoprotein(a) in Intraparenchymal Cerebral Vessels: Correlation with Vascular Pathology and Clinical History. Experimental and Molecular Pathology. 71(2). 99–105. 2 indexed citations
11.
Tangirala, Rajendra K., Domenico Praticò, Garret A. FitzGerald, et al.. (2001). Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E. Journal of Biological Chemistry. 276(1). 261–266. 98 indexed citations
12.
Tsukamoto, Kazuhisa, Rajendra K. Tangirala, Sam Chun, et al.. (2000). Hepatic Expression of Apolipoprotein E Inhibits Progression of Atherosclerosis without Reducing Cholesterol Levels in LDL Receptor-Deficient Mice. Molecular Therapy. 1(2). 189–194. 40 indexed citations
13.
Ye, Shui Qing, et al.. (1999). APstI polymorphism detects the mutation of serine128 to arginine in CD 62E gene — a risk factor for coronary artery disease. Journal of Biomedical Science. 6(1). 18–21. 39 indexed citations
14.
Simmons, Daniel T., Thomas Melendy, David Usher, & Bruce Stillman. (1996). Simian Virus 40 Large T Antigen Binds to Topoisomerase I. Virology. 222(2). 365–374. 73 indexed citations
15.
Rader, Daniel J., W. Alexander Mann, William J. Cain, et al.. (1995). The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.. Journal of Clinical Investigation. 95(3). 1403–1408. 169 indexed citations
16.
Rader, Daniel J., William J. Cain, Katsunori Ikewaki, et al.. (1994). The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.. Journal of Clinical Investigation. 93(6). 2758–2763. 177 indexed citations
17.
Rader, Daniel J., William J. Cain, Loren A. Zech, David Usher, & H. Bryan Brewer. (1993). Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.. Journal of Clinical Investigation. 91(2). 443–447. 165 indexed citations
18.
Biervliet, J.P. Van, et al.. (1991). Lipoprotein(a) profiles and evolution in newborns. Atherosclerosis. 86(2-3). 173–181. 26 indexed citations
19.
Keesler, George A., S. Moore, David Usher, & Leo W. Parks. (1991). Yeast proteins with reactivity to antibodies elicited against mammalian apolipoproteins. Biochemical and Biophysical Research Communications. 174(2). 631–637. 3 indexed citations
20.
Usher, David, et al.. (1978). Linkage between low-density lipoprotein and igk light-chain genes in rabbits. Immunogenetics. 7(1). 117–123. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026